Skip to main content
. 2014 Jan 13;2014(1):CD003559. doi: 10.1002/14651858.CD003559.pub4

10.2. Analysis.

10.2

Comparison 10 Low‐dose aerosolised omalizumab versus placebo, Outcome 2 Area under curve for fall in FEV1 (% × minutes)—late response (three to seven hours).